Chow W - Search Results

1

Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis.

Buysman EK, Chow W, Henk HJ, Rupnow MF. Buysman EK, et al. Among authors: chow w. BMC Endocr Disord. 2015 Nov 2;15:67. doi: 10.1186/s12902-015-0064-8. BMC Endocr Disord. 2015. PMID: 26527413 Free PMC article.

2

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting.

Buysman EK, Chow W, Henk HJ, Rupnow MF. Buysman EK, et al. Among authors: chow w. Curr Med Res Opin. 2015 Jan;31(1):137-43. doi: 10.1185/03007995.2014.982750. Epub 2014 Nov 12. Curr Med Res Opin. 2015. PMID: 25356602

3

Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting.

Chow W, Buysman E, Rupnow MF, Aguilar R, Henk HJ. Chow W, et al. Curr Med Res Opin. 2016;32(1):13-22. doi: 10.1185/03007995.2015.1100598. Epub 2015 Oct 27. Curr Med Res Opin. 2016. PMID: 26414434

4

Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.

Chow W, Miyasato G, Kokkotos FK, Bailey RA, Buysman EK, Henk HJ. Chow W, et al. Clin Ther. 2016 Sep;38(9):2071-82. doi: 10.1016/j.clinthera.2016.07.168. Epub 2016 Sep 3. Clin Ther. 2016. PMID: 27596020

5

Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR.

Lin J, Chow W, Kim MS, Rupnow MF. Lin J, et al. Among authors: chow w. J Med Econ. 2013;16(5):685-90. doi: 10.3111/13696998.2013.780177. Epub 2013 Mar 14. J Med Econ. 2013. PMID: 23441974 Free article.

6

Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors.

Wysham CH, Lefebvre P, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Chow W, Pfeifer M, Duh MS. Wysham CH, et al. Among authors: chow w. BMC Endocr Disord. 2017 Jun 8;17(1):32. doi: 10.1186/s12902-017-0180-8. BMC Endocr Disord. 2017. PMID: 28595617 Free PMC article.

7

Understanding preferences for type 2 diabetes mellitus self-management support through a patient-centered approach: a 2-phase mixed-methods study.

Lopez JM, Katic BJ, Fitz-Randolph M, Jackson RA, Chow W, Mullins CD. Lopez JM, et al. Among authors: chow w. BMC Endocr Disord. 2016 Jul 18;16(1):41. doi: 10.1186/s12902-016-0122-x. BMC Endocr Disord. 2016. PMID: 27430259 Free PMC article.

8

Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors.

Thayer S, Chow W, Korrer S, Aguilar R. Thayer S, et al. Among authors: chow w. Curr Med Res Opin. 2016 Jun;32(6):1087-96. doi: 10.1185/03007995.2016.1159954. Epub 2016 Mar 16. Curr Med Res Opin. 2016. PMID: 26938635

9

Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study.

Lefebvre P, Pilon D, Robitaille MN, Lafeuille MH, Chow W, Pfeifer M, Duh MS. Lefebvre P, et al. Among authors: chow w. Curr Med Res Opin. 2016 Jun;32(6):1151-9. doi: 10.1080/03007995.2016.1183604. Epub 2016 May 11. Curr Med Res Opin. 2016. PMID: 27115475

10

HbA_1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans.

Thayer S, Aguilar R, Korrer S, Chow W. Thayer S, et al. Among authors: chow w. Clin Ther. 2017 Oct;39(10):2061-2072. doi: 10.1016/j.clinthera.2017.08.019. Epub 2017 Sep 22. Clin Ther. 2017. PMID: 28943114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,705 results

Search Page

Filters